DoW Duchenne Muscular Dystrophy Clinical/Translational Award
Grant monitored from grants-gov.
- Buyer / agency
- Defense Health Agency Contracting Activity - DHACA
- Notice type
- Grant
- Solicitation number
- HT942526DMDRPCTRA
- Posted
- June 17, 2026
- Response deadline
- September 18, 2026
- Location
- US
- Estimated value
- $8,460,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. Distinctive Features…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.